A Clinical Study to Assess the Effect of Vildagliptin on Beta Cell Function in Drug Naive Patients With Type 2 Diabetes
Status:
Completed
Trial end date:
2008-12-01
Target enrollment:
Participant gender:
Summary
This study is not being conducted in the United States. The purpose of this study is to
assess the effect of vildagliptin, an unapproved drug, on various measures of pancreatic
islet function in people with type 2 diabetes who have not previously been treated with drug
therapy to lower their blood sugar.